Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-016285

MADRIGAL PHARMACEUTICALS, INC. · MDGL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 11, 2015
Accepted (ET)
Dec 15, 2015 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 11, 2015S300,000$0.3701D1,839,169IBy Wyandanch Partners, L.P.
Common StockF3,F2Dec 14, 2015S300,000$0.3223D1,539,169IBy Wyandanch Partners, L.P.
Common Stockholding———401,764D
Common Stockholding———175,000IBy Keith R. Gollust IRA

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses